|
Status |
Public on Apr 24, 2024 |
Title |
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability |
Organism |
Homo sapiens |
Experiment type |
Expression profiling by high throughput sequencing Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
This SuperSeries is composed of the SubSeries listed below.
|
|
|
Overall design |
Refer to individual Series
|
|
|
Citation(s) |
38653237 |
|
Submission date |
Feb 23, 2024 |
Last update date |
Jul 25, 2024 |
Contact name |
Mariko Sidi Takahashi |
E-mail(s) |
mhara1@mgh.harvard.edu
|
Phone |
8322671747
|
Organization name |
MGH
|
Department |
Cancer Center
|
Lab |
Bar-Peled
|
Street address |
149 13th Street, Charlestown Navy Yard
|
City |
Charlestown |
State/province |
Massachusetts |
ZIP/Postal code |
02129 |
Country |
USA |
|
|
Platforms (2) |
GPL18573 |
Illumina NextSeq 500 (Homo sapiens) |
GPL24676 |
Illumina NovaSeq 6000 (Homo sapiens) |
|
Samples (71)
|
|
This SuperSeries is composed of the following SubSeries: |
GSE256464 |
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability (ChIP-Seq) |
GSE256466 |
DrugMap: A quantitative pan-cancer analysis of cysteine ligandability (RNA-Seq) |
|
Relations |
BioProject |
PRJNA1079738 |